XORTX Therapeutics Inc (XRTX)
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
IREN Completes Acquisition of Nostrum Group Expanding AI Cloud Platform to Europe
Enhanced Group Announces $50 Million Strategic Financing Led by Enhanced Co-Founder and Chairman Christian Angermayer; Management Expects Company Fully Funded Through Profitability
OTC Markets Group Names Thomas Fasano Head of Broker-Dealer Sales
Sable Expands the Zorro Project Through New Staking and an Option Agreement of the El Acero Property, San Juan, Argentina
Village Farms Provides Operational Update on Delta 2 Greenhouse Expansion
Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer
Lightbridge to Participate in Upcoming Investor and Nuclear Industry Events
Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign
Shock Top Kicks Off the World’s Biggest Summer of Soccer with Shocking Upsets